Investing Stocks Stablecoin Development Corporation Common Stock · NBY Novartis DM1 drug fails late-stage trial, clouding development outlook Sep 8, 2026 8:57 AM · Investing Novartis DM1 drug fails late-stage trial, clouding development outlook Original source: Investing